Compare Cassava Sciences Inc (FLNA) vs Jabil Inc (JBL) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

JBL trades at $313.15, down 4.18% today amid bearish technical signals. The stock shows strong fundamentals with consistent earnings beats (Q1 2026 EPS of $3.16 vs. $3.10 expected) and robust revenue growth projections ($33.6B in 2026). Analyst sentiment is balanced with 50% buy ratings and a $436.50 consensus price target, representing significant upside potential. Recent developments include expansion of AI manufacturing capacity in India and new logistics hubs, positioning JBL for continued growth in AI infrastructure markets.

JBL presents a compelling investment case driven by AI infrastructure demand and earnings momentum, though valuation concerns and technical weakness warrant caution. The stock's 39.95 P/E ratio appears elevated, but strong ROE (20.62%) and projected profit margin expansion to 2.56% support growth expectations. Key risks include competitive pressures in electronics manufacturing and execution challenges in capacity expansion initiatives.